We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

1 hedge funds and large institutions have $5K invested in LianBio American Depositary Shares in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more capital invested

Capital invested by funds: $2K → $5K (+$3K)

0% more funds holding

Funds holding: 1 → 1 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
-$250
Name Holding Trade Value Shares
Change 		Change in
Stake
FIA
1
FNY Investment Advisers
New York
$5K -$250 -700 -5%

LIAN Hedge Fund Activity: Q2 2025 in Review

1 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q2 2025, worth a combined $5K — up 150% from $2K a quarter earlier.

Fund positioning in LIAN was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was FNY Investment Advisers, cutting an estimated $250.

  • 1 institutional investor held LianBio American Depositary Shares (LIAN) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $5K of LianBio American Depositary Shares stock for Q2 2025, up 150% quarter-over-quarter.
  • 0 funds opened new LianBio American Depositary Shares positions in Q2 2025 and 0 closed out.
  • The largest LianBio American Depositary Shares seller in Q2 2025 was FNY Investment Advisers, an estimated $250 sold.

Based on aggregated 13F filings for Q2 2025.